Ligand-regulated peptides: A general approach for modulating protein-peptide interactions with small molecules

Chemistry and Biology

Volumn 12, Issue 7, 2005, Pages 847-855

  Binkowski, Brock F ^a   Miller, Russell A ^a   Belshaw, Peter J ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5' AMP ACTIVATED PROTEIN KINASE; 5'-AMP-ACTIVATED PROTEIN KINASE; FK 506 BINDING PROTEIN; GLUTATHIONE TRANSFERASE; LIGAND; MULTIENZYME COMPLEX; PEPTIDE; PEPTIDE LIBRARY; PROTEIN KINASE P60; PROTEIN SERINE THREONINE KINASE; RETINOBLASTOMA PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; BINDING SITE; CELL CULTURE; DRUG EFFECT; DRUG INTERACTION; GENETICS; METABOLISM; PROTEIN BINDING; PROTEIN CONFORMATION;

AMINO ACID SEQUENCE; BINDING SITES; CELLS, CULTURED; DRUG INTERACTIONS; GLUTATHIONE TRANSFERASE; LIGANDS; MULTIENZYME COMPLEXES; PEPTIDE LIBRARY; PEPTIDES; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS PP60(C-SRC); RETINOBLASTOMA PROTEIN; TACROLIMUS BINDING PROTEINS;

EID: 22544454196     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chembiol.2005.05.021     Document Type: Article

References (57)

1. M. Lewandoski Conditional control of gene expression in the mouse Nat. Rev. Genet. 2 2001 743 755
2. M. Gossen, and H. Bujard Studying gene function in eukaryotes by conditional gene inactivation Annu. Rev. Genet. 36 2002 153 173
3. G.J. Hannon RNA interference Nature 418 2002 244 251
4. S.L. Schreiber The small-molecule approach to biology Chem. Eng. News 81 2003 51 61
5. P. Colas, B. Cohen, T. Jessen, I. Grishina, J. McCoy, and R. Brent Genetic selection of peptide aptamers that recognize and inhibit cyclin-dependent kinase 2 Nature 380 1996 548 550
6. M. Famulok, and S. Verma In vivo-applied functional RNAs as tools in proteomics and genomics research Trends Biotechnol. 20 2002 462 466
7. F. Hoppe-Seyler, I. Crnkovic-Mertens, E. Tomai, and K. Butz Peptide aptamers: Specific inhibitors of protein function Curr. Mol. Med. 4 2004 529 538
8. D.M. Spencer, T.J. Wandless, S.L. Schreiber, and G.R. Crabtree Controlling signal-transduction with synthetic ligands Science 262 1993 1019 1024
9. G.R. Crabtree, and S.L. Schreiber Three-part inventions: Intracellular signaling and induced proximity Trends Biochem. Sci. 21 1996 418 422
10. Y.W. Hwang, and D.L. Miller A mutation that alters the nucleotide specificity of elongation factor-Tu, a Gtp regulatory protein J. Biol. Chem. 262 1987 13081 13085
11. P.J. Belshaw, J.G. Schoepfer, K.Q. Liu, K.L. Morrison, and S.L. Schreiber Rational design of orthogonal receptor-ligand combinations Angew. Chem. Int. Ed. Engl. 34 1995 2129 2132
12. K. Shah, Y. Liu, C. Deirmengian, and K.M. Shokat Engineering unnatural nucleotide specificity for Rous sarcoma virus tyrosine kinase to uniquely label its direct substrates Proc. Natl. Acad. Sci. USA 94 1997 3565 3570
13. K. Shokat, and M. Velleca Novel chemical genetic approaches to the discovery of signal transduction inhibitors Drug Discov. Today 7 2002 872 879
14. K. Scearce-Levie, P. Coward, C.H. Redfern, and B.R. Conklin Tools for dissecting signaling pathways in vivo: Receptors activated solely by synthetic ligands Methods Enzymol. 343 2002 232 248
15. D. Picard, S.J. Salser, and K.R. Yamamoto A movable and regulable inactivation function within the steroid binding domain of the glucocorticoid receptor Cell 54 1988 1073 1080
16. M.H. Akabas, D.A. Stauffer, M. Xu, and A. Karlin Acetylcholine-receptor channel structure probed in cysteine-substitution mutants Science 258 1992 307 310
17. B. Foucaud, P. Ferret, T. Grutter, and M. Goeldner Cysteine mutants as chemical sensors for ligand-receptor interactions Trends Pharmacol. Sci. 22 2001 170 173
18. K. Levitsky, C.J. Ciolli, and P.J. Belshaw Selective inhibition of engineered receptors via proximity-accelerated alkylation Org. Lett. 5 2003 693 696
19. H.F. Ye, K.E. O'Reilly, and J.T. Koh A subtype-selective thyromimetic designed to bind a mutant thyroid hormone receptor implicated in resistance to thyroid hormone J. Am. Chem. Soc. 123 2001 1521 1522
20. S.L. Swann, J.J. Bergh, M.C. Farach-Carson, and J.T. Koh Rational design of vitamin D-3 analogues which selectively restore activity to a vitamin D receptor mutant associated with rickets Org. Lett. 4 2002 3863 3866
21. M.C.T. Hu, and N. Davidson The inducible Iac operator-repressor system is functional in mammalian-cells Cell 48 1987 555 566
22. M. Gossen, S. Freundlieb, G. Bender, G. Muller, W. Hillen, and H. Bujard Transcriptional activation by tetracyclines in mammalian-cells Science 268 1995 1766 1769
23. P.J. Belshaw, S.N. Ho, G.R. Crabtree, and S.L. Schreiber Controlling protein association and subcellular localization with a synthetic ligand that induces heterodimerization of proteins Proc. Natl. Acad. Sci. USA 93 1996 4604 4607
24. M. Thomas, S. Chedin, C. Carles, M. Riva, M. Famulok, and A. Sentenac Selective targeting and inhibition of yeast RNA polymerase II by RNA aptamers J. Biol. Chem. 272 1997 27980 27986
25. V.M. Rivera Controlling gene expression using synthetic ligands Methods 14 1998 421 429
26. G. Werstuck, and M.R. Green Controlling gene expression in living cells through small molecule-RNA interactions Science 282 1998 296 298
27. Y.L. Wang, S.Y. Tsai, and B.W. O'Malley Antiprogestin regulable gene switch for induction of gene expression in vivo Methods Enzymol. 306 1999 281 294
28. A.R. Buskirk, A. Landrigan, and D.R. Liu Engineering a ligand-dependent RNA transcriptional activator Chem. Biol. 11 2004 1157 1163
29. V.M. Rivera, X.R. Wang, S. Wardwell, N.L. Courage, A. Volchuk, T. Keenan, D.A. Holt, M. Gilman, L. Orci, and F. Cerasoli Regulation of protein secretion through controlled aggregation in the endoplasmic reticulum Science 287 2000 826 830
30. M. Vuyisich, and P.A. Beal Controlling protein activity with ligand-regulated RNA aptamers Chem. Biol. 9 2002 907 913
31. M. Mandal, and R.R. Breaker Gene regulation by riboswitches Nat. Rev. Mol. Cell Biol. 5 2004 451 463
32. R.R. Breaker Natural and engineered nucleic acids as tools to explore biology Nature 432 2004 838 845
33. G.A. Soukup, and R.R. Breaker Allosteric nucleic acid catalysts Curr. Opin. Struct. Biol. 10 2000 318 325
34. D.J. Maly, J.A. Allen, and K.M. Shokat A mechanism-based cross-linker for the identification of kinase-substrate pairs J. Am. Chem. Soc. 126 2004 9160 9161
35. J.J. Siekierka, S.H.Y. Hung, M. Poe, C.S. Lin, and N.H. Sigal A cytosolic binding-protein for the immunosuppressant Fk506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin Nature 341 1989 755 757
36. M.W. Harding, A. Galat, D.E. Uehling, and S.L. Schreiber A receptor for the immunosuppressant Fk506 is a cis-trans peptidyl-prolyl isomerase Nature 341 1989 758 760
37. J. Chen, X.F. Zheng, E.J. Brown, and S.L. Schreiber Identification of an 11-kDa Fkbp12-rapamycin-binding domain within the 289-kDa Fkbp12-rapamycin- associated protein and characterization of a critical serine residue Proc. Natl. Acad. Sci. USA 92 1995 4947 4951
38. J. Heitman, N.R. Movva, and M.N. Hall Targets for cell-cycle arrest by the immunosuppressant rapamycin in yeast Science 253 1991 905 909
39. J.W. Choi, J. Chen, S.L. Schreiber, and J. Clardy Structure of the FKBP12-rapamycin complex interacting with the binding domain of human FRAP Science 273 1996 239 242
40. N. Jullien, F. Sampieri, A. Enjalbert, and J.P. Herman Regulation of Cre recombinase by ligand-induced complementation of inactive fragments Nucleic Acids Res. 31 2003 e131
41. J. Lee, A.A. Russo, and N.P. Pavletich Structure of the retinoblastoma tumor-suppressor pocket domain bound to a peptide from HPV E7 Nature 391 1998 859 865
42. J. Liu, M.W. Albers, T.J. Wandless, S. Luan, D.G. Alberg, P.J. Belshaw, P. Cohen, C. Mackintosh, C.B. Klee, and S.L. Schreiber Inhibition of T cell signaling by immunophilin ligand complexes correlates with loss of calcineurin phosphatase activity Biochemistry 31 1992 3896 3901
43. E.J. Brown, M.W. Albers, T.B. Shin, K. Ichikawa, C.T. Keith, W.S. Lane, and S.L. Schreiber A mammalian protein targeted by G1-arresting rapamycin-receptor complex Nature 369 1994 756 758
44. S. Feng, J.K. Chen, H. Yu, J.A. Simon, and S.L. Schreiber Two binding orientations for peptides to the Src SH3 domain: development of a general model for SH3-ligand interactions Science 266 1994 1241 1247
45. P. Pellicena, and W.T. Miller Processive phosphorylation of p130Cas by Src depends on SH3-polyproline interactions J. Biol. Chem. 276 2001 28190 28196
46. K. Lim, J.X. Ho, K. Keeling, G.L. Gilliland, X.H. Ji, F. Ruker, and D.C. Carter Three-dimensional structure of Schistosoma japonicum glutathione S-transferase fused with a six-amino acid conserved neutralizing epitope of Gp41 from HIV Protein Sci. 3 1994 2233 2244
47. S.D. Liberles, S.T. Diver, D.J. Austin, and S.L. Schreiber Inducible gene expression and protein translocation using nontoxic ligands identified by a mammalian three-hybrid screen Proc. Natl. Acad. Sci. USA 94 1997 7825 7830
48. H. Chong, A. Ruchatz, T. Clackson, V.M. Rivera, and R.G. Vile A system for small-molecule control of conditionally replication-competent adenoviral vectors Mol. Ther. 5 2002 195 203
49. M.S. Lee, I. Kojima, and A.L. Demain Effect of nitrogen source on biosynthesis of rapamycin by Streptomyces hygroscopicus J. Ind. Microbiol. Biotechnol. 19 1997 83 86
50. T. Kino, H. Hatanaka, M. Hashimoto, M. Nishiyama, T. Goto, M. Okuhara, M. Kohsaka, H. Aoki, and H. Imanaka FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics J. Antibiot. (Tokyo) 40 1987 1249 1255
51. P. James, J. Halladay, and E.A. Craig Genomic libraries and a host strain designed for highly efficient two-hybrid selection in yeast Genetics 144 1996 1425 1436
52. M.C. Lorenz, and J. Heitman TOR mutations confer rapamycin resistance by preventing interaction with FKBP12-rapamycin J. Biol. Chem. 270 1995 27531 27537
53. M.I. Chiu, H. Katz, and V. Berlin Rapt1, a mammalian homolog of yeast Tor, interacts with the FKBP12/rapamycin complex Proc. Natl. Acad. Sci. USA 91 1994 12574 12578
54. A. Wach PCR-synthesis of marker cassettes with long flanking homology regions for gene disruptions in S. cerevisiae Yeast 12 1996 259 265
55. C.R. Geyer Peptide aptamers: Dominant "genetic" agents for forward and reverse analysis of cellular processes F.M. Ausubel R. Brent R.E. Kingston D.D. Moore J.G. Seidman J.A. Smith K. Struhl Current Protocols in Molecular Biology 2000:John Wiley and Sons, Inc. New York 24.24.21 24.24.25
56. P. James Yeast two hybrid vectors and strains P.N. MacDonald Two Hybrid Systems: Methods and Protocols, Volume 177 2001 Humana Press Inc. Clifton, NJ 41 84
57. A. Byrd, and R. St-Arnaud Strategies for rescuing plasmid DNA from yeast two-hybrid colonies P.N. MacDonald Two Hybrid Systems: Methods and Protocols, Volume 177 2001 Humana Press Inc. Clifton, NJ 107 122